Renal cell carcinoma (RCC) is a common form of urologic tumor that originates from the
highly heterogeneous epithelium of renal tubules. Over the last decade, targeting therapies …

The management of patients with metastatic renal cell carcinoma (RCC) has changed
dramatically over the past few years. Nephrectomy remains an important intervention for …

Cancer cells are characterized by indefinite proliferation, invasiveness and metastases.
These characteristics are usually related to one another. Namely, cancer cells that …

Renal cell carcinoma (RCC) is a prototype of a chemorefractory tumor. It remains the most
lethal of the common urologic cancers, with approximately 40% of patients eventually dying …

Renal cell carcinoma (RCC) is a major neoplasm with high incidence in western countries.
Tumors are heterogeneous and are composed of differentiated cancer cells, stromal cells …

Kidney cancer represents about 5% of all new cancer diagnoses. The most common form of
kidney cancer arises from renal epithelium, named renal cell carcinoma (RCC). This entity …

Abstract Treatment for renal cell carcinoma (RCC) has improved dramatically over the last
decade, shifting from high-dose cytokine therapy in combination with surgical resection of …

Evolving therapeutic targets in renal cell carcinoma : Current Opinion in Oncology Evolving
therapeutic targets in renal cell carcinoma : Current Opinion in Oncology Log in or Register …

Renal cell carcinoma has become a model disease for rationally targeted therapeutics
based on significant understanding of the underlying biology. Recent advances have …

Renal cell carcinoma: molecular biology and targeted therapy : Current Opinion in Oncology
Renal cell carcinoma: molecular biology and targeted therapy : Current Opinion in Oncology …